Attached files
file | filename |
---|---|
10-K - FORM 10-K - ALBIREO PHARMA, INC. | y80991e10vk.htm |
EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | y80991exv21w1.htm |
EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | y80991exv23w1.htm |
EX-32.01 - EX-32.01 - ALBIREO PHARMA, INC. | y80991exv32w01.htm |
EX-10.22 - EX-10.22 - ALBIREO PHARMA, INC. | y80991exv10w22.htm |
EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | y80991exv31w02.htm |
EX-10.19 - EX-10.19 - ALBIREO PHARMA, INC. | y80991exv10w19.htm |
EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | y80991exv31w01.htm |
Exhibit 10.20
SUMMARY OF THE REGISTRANTS NON-EMPLOYEE DIRECTOR COMPENSATION
The Company pays each of its non-employee directors $30,000 annually or $60,000 annually to
its lead director. In addition, non-employee directors receive the following committee-related fees
annually: (1) $7,500 for participating on the Audit Committee or $15,000 for chairing the
committee; (2) $5,000 for participating on the Compensation Committee or $15,000 for chairing the
committee; (3) $2,500 for participating on the Nominating and Governance Committee or $5,000 for
chairing the committee; (4) $7,500 for participating on the Strategy Committee.
In accordance with the Companys 2005 Non-Employee Directors Stock Option Plan, upon
appointment, non-employee directors receive a one-time grant of an option to purchase 25,000 share
of common stock. Effective March 3, 2009, the vesting period changed from immediately vesting to
vesting prorata over one year. Annually, non-employee directors receive an option to purchase
20,000 shares of common stock, which also vest prorata over one year. The exercise price of these
options is the fair market value on the date of grant. Each such option expires ten years after the
date of grant.
The Company reimburses its non-employee directors for reasonable expenses incurred in
connection with attending board and committee meetings.